Abrocitinib In The Treatment Of Moderate to Severe Atopic Dermatitis

Abrocitinib In The Treatment Of Moderate to Severe Atopic Dermatitis Overview This study examined the efficacy and safety of abrocitinib, a treatment for moderate-to-severe atopic dermatitis (AD), specifically focusing on patients with allergic comorbidities.   Data from phase 2b and phase 3 trials were analyzed, pooling information from patients who received abrocitinib or

Dermatitis And Allergies To Cosmetic Ingredients

Dermatitis And Allergies To Cosmetic Ingredients Overview In the realm of hair cosmetics, a plethora of products harbor various potent contact allergens, including additives such as preservatives. This concern is particularly pronounced among individuals involved in hairdressing, who frequently manifest hand dermatitis. Furthermore, clients and self-users, hereafter referred to as 'consumers,' may

Abrocitinib In The Treatment Of Moderate to Severe Atopic Dermatitis